Skip to content
value.today

AnBio Therapeutics Ltd.

🇺🇸 New York, New York, USABiotechnologyFounded 2021
Total raised
$61 M
1 round on record
Latest round
$61 M
Sep 2021
First round on record
Sep 2021
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of AnBio Therapeutics Ltd.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2021$61 MNo. 1$50 to $250 million

AnBio Therapeutics Ltd.: Raise no. 1, Sep 2021

Investors in this round

13 investors had bought by the notice of Oct 13, 2021: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$61 M of $61 M offered
Smallest investment taken
$200,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$1,837,500
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Bing Yan · Executive Officer, Director
  • Junyuan Wang · Executive Officer, Director
  • Lihua Zheng · Executive Officer, Director
  • Ting Jia · Director
  • Wei Xu · Director
  • Xiaohang (Tony) Tong · Director
  • Zhengwei Zhu · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lihua Zheng, Chief Business Officer and Director. Source: SEC Form D, newest notice filed Oct 13, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • AnBio Therapeutics Ltd. chose not to state its revenue in its newest notice of a funding round (Oct 2021).

    SEC Form D · Oct 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2021

That is all the official record says: AnBio Therapeutics Ltd. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of AnBio Therapeutics Ltd. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by AnBio Therapeutics Ltd.
NameRoleNamed in
Bing YanExecutive officerOct 2021
Junyuan WangExecutive officerOct 2021
Lihua ZhengExecutive officerOct 2021
Bing YanDirectorOct 2021
Junyuan WangDirectorOct 2021
Lihua ZhengDirectorOct 2021
Ting JiaDirectorOct 2021
Wei XuDirectorOct 2021
Xiaohang (Tony) TongDirectorOct 2021
Zhengwei ZhuDirectorOct 2021